By CHAD BRAY
The deal would further bolster Jazz’s portfolio by acquiring the maker of Vyxeos, a treatment for a form of leukemia.
Published: June 1, 2016 at 12:00AM
from NYT Business Day http://ift.tt/1TTyoIm
from WordPress http://ift.tt/25wbcoO
via Hadi Aboukhater
No comments:
Post a Comment